Pulmonx Corp
Research Pulmonx Corp (LUNG) on Bullrun: market cap USD 56.18M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLUNG
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 56.18M
- Financial periodFY2025
- RevenueUSD 90.50M
- Revenue growth8.0%
- Net income-USD 54.00M
- Free cash flow-USD 32.83M
- Gross margin74.2%
Valuation Snapshot
latest market cap is USD 56.18M.
About Pulmonx Corp
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.
Frequently asked questions
What is Pulmonx Corp's market cap?
Pulmonx Corp's market capitalization is USD 56.18M.
What does Pulmonx Corp do?
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve;